Clinical Trial Update: Oral Gallium Maltolate for Recurrent Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

This document reports an early-phase clinical trial evaluating oral gallium maltolate for recurrent Glioblastoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Gallium maltolate (gallium maltolate)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Glioblastoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING